MAIA Biotechnology Inc. (MAIA NYSE MKT) stock market data APIs
$1.7593
-0.06(-3.4%)
as of June 27, 2025
Try our APIs with
free plan!
MAIA Biotechnology Inc. Financial Data Overview
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Prev. Close
1.7593
Open
1.6993
High
1.8032
Low
1.6993
52 wk Range
1.4-4.24
Market Cap
54 464 K
Shares Outstanding
30 771 K
EPS
-0.16
Beta
0.045
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MAIA Biotechnology Inc. data using free add-ons & libraries
Get MAIA Biotechnology Inc. Fundamental Data
MAIA Biotechnology Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.18
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MAIA Biotechnology Inc. News
New
Maia Biotechnology enters stock purchase agreement for up to $587,905 with Prevail Partners
Maia Biotechnology, Inc. (NYSE American:MAIA), a biotechnology company with a market capitalization of $52.7 million, announced it has entered into a stock purchase agreement with Prevail Partners, LL...
MAIA Biotechnology appoints HCC experts to scientific advisory board
CHICAGO - MAIA Biotechnology, Inc. (NYSE American:MAIA), a $52.43 million market cap biotechnology company currently trading at $1.73 per share, has appointed two oncologists specializing in hepatocel...
MAIA Biotechnology, Roche sign supply agreement for cancer therapies
MAIA Biotechnology (MAIA) announced its entry into a clinical master supply agreement with Roche (RHHBY) for future studies. The agreement will investigate the combination of MAIA’s telomere-targeti...
MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical-stage biopharmaceutical company, has announced a private placement agreement to raise approximately $695,000. The company will issue 463,332 shares of ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
